Vflow21

Vflow21 is a medical device company developing innovative solutions for neurovascular diseases, focusing on vascular stents with a unique delivery system.

Health Tech & Life Sciences
Active
Series A Tel Aviv-Yafo, Israel Founded 2021
Last updated 2026-07-26
Total raised
Last: Undisclosed Round 2025-04
Stage
Series A
Founded
2021
Headcount
5
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences

About

Vflow21 is an Israeli medical device company that develops innovative solutions for neurovascular diseases. The company focuses on Idiopathic Intracranial Hypertension and Tinnitus Treatment. Their primary product is VivaStent, a device for the treatment of cerebral venous insufficiency, featuring a unique delivery system designed for safe and swift trackability and deployment in tortuous cerebral venous anatomy. Vflow21 is also developing two more future products for cerebral arterial pathologies, both of which will incorporate Vflow's unique delivery system.

Funding history · 2 rounds · — total

2025-03
B Round Undisclosed
★ Sanara Capital
2023-05
A Round Undisclosed
★ Israel Innovation Authority

Headcount over time

From 3 (2024-01) to 6 (2026-03) · +3 (+100%) · 6 points · source: Finder history + radar grounding
70 2024-01 2026-03

Q&A

What is Vflow21's primary focus in medical device development?
Vflow21 is a medical device company developing innovative solutions for neurovascular diseases, with a focus on Idiopathic Intracranial Hypertension and Tinnitus Treatment.
What is Vflow21's main product?
Vflow21's primary product is VivaStent, a device designed for the treatment of cerebral venous insufficiency, featuring a unique delivery system for safe and swift deployment.
How many employees does Vflow21 currently have?
Vflow21 has 5 employees, falling within the 1-10 employee bucket.
Who are the co-founders of Vflow21?
The co-founders of Vflow21 are Dr. Bilha Cahana and Dr. Anat Horev.
Which investor participated in Vflow21's Seed round?
Sanara Capital Ventures participated in Vflow21's Seed round in February 2025.
What is Vflow21's current product development stage?
Vflow21's products are currently in the R&D stage.

Team · 2

Dr. Bilha Cahana
Founder · Co-founder
Dr. Anat Horev
Founder · Co-founder & CMO

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Tags

stentvascularneurovascularmedical-devices
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)